Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Addressing the multiple facets of ligand-receptor network inference

ABSTRACT: Part of a broader study about ligand-receptor interaction inference and a new framework expanding our SingleSignalR tool, we show how particular experimental designs, incuding bulk analyses, can be handled by this single-cell-orientate tool. Among these, the case of PDX is illustrated with a collection of PDAC PDX whose bulk RNA-sequencing data are made available here.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE309679 | GEO | 2026/07/22

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Addressing the multiple facets of ligand-receptor network inference

Project description:Addressing the multiple facets of ligand-receptor network inference

| PRJNA1336729 | ENA

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

Project description:Developing animal models representating the cancer biology of advanced prostate cancer patients is challenging but essential for delivering individualized medical therapies. In an effort to develop patient derived xenograft (PDX) models, we took the metastatic site tissue from the rib lesion twice (ie, before and after enzalutamide treatment) over a twelve week period and implanted subcutaneously and under the renal capsule in immuno-deficient mice. To characterize and compare the genome and transcriptome landscapes of patient tumor tissues and the corresponding PDX models, we performed whole exome and transcriptome sequencing for metastatic tumor tissue as well as its derived PDXs. We demonstrated the feasibility of developping PDX models from patient who developed castrate-resistant prostate cancer. Our data suggested PDX models preserve the patient’s genomic and transcriptomic alterations in high fidelity, as illustrated by somatic mutation, copy number variation, gene fusion and gene expression. RNA sequencing of prostate cancer tumor tissue and derived xenograft using Illumina HiSeq 2000.

2015-06-30 | E-GEOD-70380 | biostudies-arrayexpress

Ligand-receptor promiscuity enables cellular addressing.

Project description: Not available

| S-EPMC10897978 | biostudies-literature

Xenografting of advanced stage breast cancer preserves the genomic and clonal architecture and captures luminal tumors harboring mutations and gene rearrangements in ESR1

Project description:End-stage breast cancers are clonally heterogeneous and harbor many poorly-understood treatment resistance mechanisms. We therefore established multiple Patient-Derived-Xenograft (PDX) models to study genomic events driving advanced disease. Comparative whole-genome sequencing of paired primary tumors and their PDX models demonstrated that PDX retain the vast majority of the structural variations and copy number aberrations seen within the originating tumor, and with high fidelity. Variant allele fractions (VAF) were preserved, even for rare mutations. Clonal representation is therefore a transplantable phenotype, indicating that genomic heterogeneity can be regulated in a tumor-autonomous mechanism, indifferent to host immune status. Mutations and gene rearrangements were documented in the ESR1 gene in three of five sequenced luminal PDX/progenitor tumor pairs (amplification, point mutation and translocation), and were associated with clinical endocrine response phenotypes, differential PDX estradiol responsiveness and all induced estradiol-independent growth in standard cell lines. PDX models are therefore a significant new tool for fundamental studies on the molecular basis for resistance to endocrine treatment in advanced breast cancer. reference x sample

2013-12-22 | E-GEOD-46604 | biostudies-arrayexpress

Addressing missing data in randomized clinical trials: A causal inference perspective.

Project description: Not available

| S-EPMC7337281 | biostudies-literature

2126f067-dc14-4271-9adf-21a30ba15e14 - samples

Project description:This dataset contains raw fastq files from the RNA-Seq of 96 T-Acute Lymphoblastic Leukemia. Libraries where prepared using Agilent SureSelect XT-HS2 RNA Reagent Kit. As such, reads contain molecular barcodes that could be specifically handled using the AGeNT tool.

| EGAD00001010273 | EGA

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

2015-06-30 | GSE70380 | GEO

Addressing Ligand-Based Redox in Molybdenum-Dependent Methionine Sulfoxide Reductase.

Project description: Not available

| S-EPMC7937415 | biostudies-literature

Addressing transcriptomic assay heterogeneity for predictive modeling in cancer (NanoString)

Project description:The goal of this study was to evaluate how best to preprocess RNA-seq and NanoString data to, if possible, combine these data for larger cohort sizes in predictive modeling of clinical features. High-grade serous Ovarian Cancer is a highly heterogeneous disease with most data split into Microarray, NanoString, and RNA-seq. NanoString and RNA-seq showed the greatest similarities in dynamic range across these datasets. Therefore, we performed bulk RNA-seq and NanoString (PanCancer IO360 panel) on sequential samples of 26 patients to evaluate how comparable gene expression patterns were captured and if preprocessing steps could improve this. In the preprocessing steps for RNA-seq, we considered counting over genes or exons to which NanoString probes mapped.

2026-03-31 | GSE322784 | GEO

flg22 treatment & mutants-Gene profiling upon biotic stress treatment. Gene profiling in microRNA mutants.

Project description:rs06-06_mirna - flg22 treatment & mutants - Time course : What are the genes (incuding microRNA precursors) that are differentially regulated upon flg22 treatment? miRNA : What are the genes (including miRNA precursors) that are differentially regulated in a set of microRNA mutants? siRNA : What are the genes (including miRNA precursors) that are differentially regulated in a set of siRNA mutants? - What are the genes (incuding microRNA precursors) that are differentially regulated upon flg22 treatment? 14-day old seedlings treated with flg22 (flagellin- derived peptide). Keywords: time course,total transcriptome knowledge

2008-06-02 | GSE10383 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data